Table 1.

Characteristics of included studies.

Author and year of publication	Language administered	Name of instrument	How completed	Participant age	Patients enrolled	Number enrolled	Timing	Number of assessments	Psychometric evaluation	Participant bias	Analysis bias
Kennedy et al., 2014	NA	Health Utilities Index	In person	Age distribution not shown for those who self-reported	Radiation for medulloblastoma	NA	Off therapy	Once	None mentioned	Moderate risk	Moderate risk
Einarsson et al., 2011	Swedish	Hearing Measurement Scale	In person	Median 27.5 years (range 17.7–33.9) for hearing impaired and 23.5 (range 15.5–30.4) for normal hearing	Platinum	15	Off therapy	Once	None mentioned	High risk	High risk
Einar-Jon et al., 2011	Icelandic	Hearing Measurement Scale	In person	Median 14.1 years (range 11.1–30.1)	Platinum	15	Off therapy	Once	None mentioned	High risk	Moderate risk
Fu (Fu et al., 2006)	Spanish	Health Utilities Index	In person	Age distribution not shown for those who self-reported	Any cancer	NA	Off therapy	Once	None mentioned	High risk	High risk
Barr et al., 2000	English	Health Utilities Index	Mail	Age distribution not shown for those who self-reported	Advanced stage Wilms' tumor and neuroblastoma	51	Off therapy	Once	None mentioned	Moderate risk	Moderate risk
Soussi & Otto, 1994	English	Tinnitus Questionnaire for Auditory Brainstem Implant	NA	Median 29 years (range 18–63)	Auditory brainstem implant in bilateral acoustic neurofibromas	16	Off therapy	Once	None mentioned	High risk	High risk

Note. NA = not available.